Name of Activity: Interdisciplinary Webinar Series: Drug Therapy for Neuropathic Pain in the Medically Ill
Funding Disclosure: No commercial funding has been accepted for the activity. The Institute gratefully acknowledges the donation of Cynthia Zirinsky for this project.
Date and Time: December 23, 2014, 12:30 PM – 1:15 PM ET (Live) Location: Online
Speaker Name and Title:
Russell K. Portenoy, MD
Executive Director, MJHS Institute for Innovation in Palliative Care
Chief Medical Officer, MJHS Hospice and Palliative Care
Professor of Neurology, Albert Einstein College of Medicine
Purpose: The purpose of this activity is to update learners on a variety of drug classes and drugs used to treat neuropathic pain in medically ill populations, and to enhance their ability to provide care based on current best evidence.
Objectives: Participants will be able to:
- Identify the diverse phenomenologies of neuropathic pain.
- Recognize pharmacotherapy as the mainstay approach to treatment.
- Discuss the roles of opioids, adjuvant analgesics, and nonsteroidal anti-inflammatory drugs in the treatment of neuropathic pain.
Target Audience: palliative care specialists, pain specialists, primary care providers, nurse practitioners, registered nurses, advance practice nurses, registered nurses with a specialty in palliative care/hospice, pharmacists, allied health professionals, fellows, residents, and medical students
Criteria for Successful Completion:
Attendance at entire session
Submission of completed evaluation form (mandatory for nurses)
Continuing Education Credits: 0.75
CME Approval Date: October 15, 2014
Expiration Date for Enduring Material:
CME credits: December 22, 2015
Nursing CE credits: December 22, 2015
Accreditation Statement — CME
This activity has been planned and implemented in accordance with the Accreditation Requirements and Policies of the Medical Society of the State of New York (MSSNY) through the joint providership of MSSNY and the MJHS Institute for Innovation in Palliative Care. MSSNY is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Medical Society of the State of New York designates this live activity for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Accreditation Statement — Nursing CEs
This continuing nursing education activity was approved by the Alabama State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.
Approval # 2-0.1432.
Policies and standards of the Medical Society of the State of New York and the Accreditation Council for Continuing Medical Education, and the Alabama State Nursing Association require that speakers and planners for continuing medical education activities disclose any relevant financial relationships they may have with commercial interests whose products, devices or services may be discussed in the content of a CME/CE activity.
Russell K. Portenoy, MD, Planner/Presenter, has indicated a relationship with the following: Pfizer Inc.
No other Planning Committee Member has any disclosures.